Clinical Trial Update: Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lutein, zeaxanthin and Brilliant Blue G in chromovitrectomy for epiretinal membrane and macular hole, with proliferative diabetic retin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epiretinal Membrane
• Macular Hole
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Brilliant Blue G (Brilliant Blue G)
• Lutein (lutein)
• Zeaxanthin (Zeaxanthin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Epiretinal Membrane, Macular Hole | Phase 3 | Status: COMPLETED